150 related articles for article (PubMed ID: 27437776)
1. YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acid.
Xu G; Wang J; Wu F; Wang N; Zhou W; Wang Q; Pan W; Ao G; Yang J
Oncotarget; 2016 Aug; 7(32):52150-52165. PubMed ID: 27437776
[TBL] [Abstract][Full Text] [Related]
2. Molecular evidence for better efficacy of hypocrellin A and oleanolic acid combination in suppression of HCC growth.
Wang L; Wang J; Cao Y; Li W; Wang Y; Xu J; Xu G
Eur J Pharmacol; 2019 Jan; 842():281-290. PubMed ID: 30391347
[TBL] [Abstract][Full Text] [Related]
3. Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells.
Li Y; Xu Q; Yang W; Wu T; Lu X
Gene; 2019 Sep; 712():143956. PubMed ID: 31271843
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells.
Lange M; Abhari BA; Hinrichs TM; Fulda S; Liese J
Biochem Pharmacol; 2016 Oct; 118():9-17. PubMed ID: 27544320
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
Chen L; Zhang Y; Kong X; Lan E; Huang Z; Peng S; Kaufman DL; Tian J
J Med Chem; 2008 Aug; 51(15):4834-8. PubMed ID: 18598019
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-hepatocellular carcinoma activity of novel O
Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
[TBL] [Abstract][Full Text] [Related]
8. [YAP regulates the proliferation and modifies the sensitivity to sorafenib in hepatocellular carcinoma cells].
Guo LW; Shao GL; Luo J; Hao WY; Yao Z; Zheng JP
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):818-823. PubMed ID: 30481931
[No Abstract] [Full Text] [Related]
9. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
[No Abstract] [Full Text] [Related]
10. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
Gao C; Li X; Yu S; Liang L
J BUON; 2019; 24(5):1964-1969. PubMed ID: 31786862
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
Chattopadhyay M; Kodela R; Nath N; Dastagirzada YM; Velázquez-Martínez CA; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):715-22. PubMed ID: 22222427
[TBL] [Abstract][Full Text] [Related]
12. Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells.
Liese J; Abhari BA; Fulda S
Cancer Lett; 2015 Aug; 365(1):47-56. PubMed ID: 25917078
[TBL] [Abstract][Full Text] [Related]
13. YAP activation is an early event and a potential therapeutic target in liver cancer development.
Perra A; Kowalik MA; Ghiso E; Ledda-Columbano GM; Di Tommaso L; Angioni MM; Raschioni C; Testore E; Roncalli M; Giordano S; Columbano A
J Hepatol; 2014 Nov; 61(5):1088-96. PubMed ID: 25010260
[TBL] [Abstract][Full Text] [Related]
14. Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells.
Liese J; Hinrichs TM; Lange M; Fulda S
Anticancer Drugs; 2019 Mar; 30(3):209-217. PubMed ID: 30640794
[TBL] [Abstract][Full Text] [Related]
15. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP.
Shyu MH; Kao TC; Yen GC
J Agric Food Chem; 2010 May; 58(10):6110-8. PubMed ID: 20415421
[TBL] [Abstract][Full Text] [Related]
16. Optimized formulation of multivesicular liposomes loaded with oleanolic acid enhanced anticancer effect in vitro.
Wang Y; Luo Y; Li C; Zhang X; Pi C; Yu L; Wang S; Zhong Z
Drug Des Devel Ther; 2017; 11():955-968. PubMed ID: 28392677
[TBL] [Abstract][Full Text] [Related]
17. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.
Wang Y; Fang R; Cui M; Zhang W; Bai X; Wang H; Liu B; Zhang X; Ye L
Cancer Lett; 2017 Jan; 385():234-242. PubMed ID: 27765671
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
[TBL] [Abstract][Full Text] [Related]
19. Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo.
Luo Y; Liu Z; Zhang X; Huang J; Yu X; Li J; Xiong D; Sun X; Zhong Z
Int J Nanomedicine; 2016; 11():3111-29. PubMed ID: 27471381
[TBL] [Abstract][Full Text] [Related]
20. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo.
Lee ZW; Zhou J; Chen CS; Zhao Y; Tan CH; Li L; Moore PK; Deng LW
PLoS One; 2011; 6(6):e21077. PubMed ID: 21701688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
